Characteristics | No. | % |
---|---|---|
Sex | Â | Â |
*female | 16 | 30.77 |
*male | 36 | 69.23 |
Age | Â | Â |
* < 50 | 16 | 30.77 |
* ≥ 50 | 36 | 69.23 |
*mean (SD) | 53.73 (11.35) | Â |
*median (range) | 54 (25-70) | Â |
Performance status | Â | Â |
*0 | 2 | 3.85 |
*1 | 24 | 46.15 |
*2 | 26 | 50 |
Baseline Hemoglobin | Â | Â |
*mean (SD) | 12.39 (1.89) | Â |
*median (range) | 12 (9.9-15.8) | Â |
Site of primary tumor | Â | Â |
* nasopharynx | 4 | 7.69 |
* hypopharynx | 8 | 15.38 |
* larynx | 26 | 50 |
* maxilla | 2 | 3.85 |
* paranasal sinus | 2 | 3.85 |
* tongue | 10 | 19.23 |
T stage | Â | Â |
*T1 | 4 | 7.69 |
*T2 | 12 | 23.08 |
*T3 | 20 | 38.46 |
*T4 | 16 | 30.77 |
N stage | Â | Â |
* N0 | 10 | 19.23 |
* N1 | 10 | 19.23 |
* N2 | 32 | 61.54 |
Grade | Â | Â |
*I | 4 | 7.7 |
*II | 34 | 65.4 |
*III | 14 | 26.9 |
Stage | Â | Â |
*III | 26 | 50 |
*IVa | 26 | 50 |